Style | Citing Format |
---|---|
MLA | Mehvari Habibabadi J, et al.. "Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis." Neurological Sciences, vol. 40, no. 3, 2019, pp. 495-502. |
APA | Mehvari Habibabadi J, Badihian S, Tabrizi N, Manouchehri N, Zare M, Basiratnia R, Barekatain M, Moein H, Mehvari Habibabadi A, Moein P, Gookizadeh P (2019). Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis. Neurological Sciences, 40(3), 495-502. |
Chicago | Mehvari Habibabadi J, Badihian S, Tabrizi N, Manouchehri N, Zare M, Basiratnia R, Barekatain M, et al.. "Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis." Neurological Sciences 40, no. 3 (2019): 495-502. |
Harvard | Mehvari Habibabadi J et al. (2019) 'Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis', Neurological Sciences, 40(3), pp. 495-502. |
Vancouver | Mehvari Habibabadi J, Badihian S, Tabrizi N, Manouchehri N, Zare M, Basiratnia R, et al.. Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis. Neurological Sciences. 2019;40(3):495-502. |
BibTex | @article{ author = {Mehvari Habibabadi J and Badihian S and Tabrizi N and Manouchehri N and Zare M and Basiratnia R and Barekatain M and Moein H and Mehvari Habibabadi A and Moein P and Gookizadeh P}, title = {Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis}, journal = {Neurological Sciences}, volume = {40}, number = {3}, pages = {495-502}, year = {2019} } |
RIS | TY - JOUR AU - Mehvari Habibabadi J AU - Badihian S AU - Tabrizi N AU - Manouchehri N AU - Zare M AU - Basiratnia R AU - Barekatain M AU - Moein H AU - Mehvari Habibabadi A AU - Moein P AU - Gookizadeh P TI - Evaluation of Dual Pathology Among Drug-Resistant Epileptic Patients With Hippocampal Sclerosis JO - Neurological Sciences VL - 40 IS - 3 SP - 495 EP - 502 PY - 2019 ER - |